This is a UK news story, published by The Conversation.
For more UK news, you can click here:
more UK newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from The Conversation, you can click here:
more news from The ConversationOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
human clinical trials. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest animal trials news, drug development decisions news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
clinical trialsThe Conversation
•91% Informative
Swiss and UK researchers looked at what percentage of therapies successfully moved from animal studies to human use, the time this took, and whether the results from animal and human studies agreed.
They assessed the quality of the included studies using a meta-analysis (which combines the results of several studies) to work out whether positive outcomes in animal studies translated into positive outcomes from human studies.
For those that were successful, the process took an average ten years .
VR Score
94
Informative language
95
Neutral language
60
Article tone
informal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
15
Source diversity
14
Affiliate links
no affiliate links